Literature DB >> 2841974

Phosphorylation and dephosphorylation of purified phospholamban and associated phosphatidylinositides.

G Jakab1, E G Kranias.   

Abstract

Phospholamban, the putative regulator for the calcium pump, was purified to apparent homogeneity and in high yields from canine cardiac sarcoplasmic reticulum membranes. Purified phospholamban migrated with an apparent Mr of 27,000 in alkaline sodium dodecyl sulfate-polyacrylamide gels, and upon boiling in 7.5% sodium dodecyl sulfate, it dissociated into a lower molecular weight component of 5500-6000. Purified phospholamban contained 0.62 +/- 0.09 mumol of lipid Pi/mg of protein, and the major phospholipids were phosphatidylserine (34%), phosphatidylcholine (22%), sphingomyelin (17%), phosphatidylinositol (13%), and phosphatidylethanolamine (9%). Phospholamban was phosphorylated by cAMP-dependent protein kinase to a level of 207 nmol of Pi/mg, and this would indicate an incorporation of 1 mol of phosphate/mol of protein, assuming a molecular weight of 5500 for phospholamban. Phosphorylation of phospholamban could be reversed by a "phospholamban phosphatase" isolated from canine cardiac cytosol. Phospholipids associated with the purified phospholamban were also phosphorylated in the presence of the catalytic subunit of cAMP-dependent protein kinase, and the maximal phosphate incorporation was 4 nmol/mg of protein. The main phospholipids phosphorylated were phosphatidylinositol 4-monophosphate and phosphatidylinositol 4,5-bisphosphate. Phosphorylation of phospholipids was inhibited by the heat-stable inhibitor protein of the cAMP-dependent protein kinase, and it could be also reversed by the phospholamban phosphatase.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841974     DOI: 10.1021/bi00410a042

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban.

Authors:  H Verboomen; F Wuytack; H De Smedt; B Himpens; R Casteels
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

2.  The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum.

Authors:  B A Davis; I Edes; R C Gupta; E F Young; H W Kim; N A Steenaart; G Szymanska; E G Kranias
Journal:  Mol Cell Biochem       Date:  1990-12-20       Impact factor: 3.396

3.  Regulation of rat cardiac nuclei-associated Mg(2+)-NTPase by phosphorylation.

Authors:  R C Gupta; E F Young; D G Ferguson; E G Kranias
Journal:  Mol Cell Biochem       Date:  1991-04-10       Impact factor: 3.396

4.  Characterization of the molecular form of cardiac phospholamban.

Authors:  J M Harrer; E G Kranias
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

5.  Regulation of the skeletal sarcoplasmic reticulum Ca(2+)-ATPase by phospholamban and negatively charged phospholipids in reconstituted phospholipid vesicles.

Authors:  G Szymańska; H W Kim; J Cuppoletti; E G Kranias
Journal:  Mol Cell Biochem       Date:  1992-09-08       Impact factor: 3.396

6.  Synthetic phosphopeptides enable quantitation of the content and function of the four phosphorylation states of phospholamban in cardiac muscle.

Authors:  Naa-Adjeley D Ablorh; Xiaoqiong Dong; Zachary M James; Qiang Xiong; Jianyi Zhang; David D Thomas; Christine B Karim
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.